HC Wainwright & Co. Reiterates Buy Rating on Celcuity Inc. (CELC)

Market Context

Celcuity Inc. operates in the Healthcare sector. The stock currently trades at $70.37 with a market capitalization of $4.7B. The stock has declined 10.5% over the past 52 weeks.

Analyst coverage from HC Wainwright & Co. provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Celcuity Inc.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Celcuity Inc.

Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Nov 09, 2026	HC Wainwright & Co.	Buy	N/A
Nov 06, 2026	Guggenheim	Buy	N/A
Oct 22, 2026	Cantor Fitzgerald	Overweight	N/A
Oct 21, 2026	TD Cowen	Buy	N/A
Sep 30, 2026	Needham	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View CELC Stock Page